Similar articles

• Pseudomonas aeruginosa infection in cystic fibrosis: biosynthesis of alginate as a virulence factor.

  Roychoudhury S, Zielinski NA, DeVault JD, Kato J, Shinabarger DL, May TB, Maharaj R, Kimbara K, Misra TK, Chakrabarty AM. Roychoudhury S, et al. Antibiot Chemother (1971). 1991;44:63-7. doi: 10.1159/000420299. Antibiot Chemother (1971). 1991. PMID: 1801646 Review. No abstract available.
• Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.

  Pedersen SS. Pedersen SS. APMIS Suppl. 1992;28:1-79. APMIS Suppl. 1992. PMID: 1449848 Review.
• Pseudomonas in cystic fibrosis sylph or sycophant?

  Fick RB Jr. Fick RB Jr. Clin Chest Med. 1981 Jan;2(1):91-102. Clin Chest Med. 1981. PMID: 7030601 Review. No abstract available.
• Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.

  Gill JF, Deretic V, Chakrabarty AM. Gill JF, et al. Microbiol Sci. 1987 Oct;4(10):296-9. Microbiol Sci. 1987. PMID: 3155272 Review.
• Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.

  Ramsey DM, Wozniak DJ. Ramsey DM, et al. Mol Microbiol. 2005 Apr;56(2):309-22. doi: 10.1111/j.1365-2958.2005.04552.x. Mol Microbiol. 2005. PMID: 15813726 Review.